WO2018093238A3 - 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 - Google Patents
포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 Download PDFInfo
- Publication number
- WO2018093238A3 WO2018093238A3 PCT/KR2017/013297 KR2017013297W WO2018093238A3 WO 2018093238 A3 WO2018093238 A3 WO 2018093238A3 KR 2017013297 W KR2017013297 W KR 2017013297W WO 2018093238 A3 WO2018093238 A3 WO 2018093238A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- obesity
- strain
- composition
- active ingredient
- formic acid
- Prior art date
Links
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 title abstract 8
- 208000008589 Obesity Diseases 0.000 title abstract 6
- 235000020824 obesity Nutrition 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 title abstract 4
- 239000004480 active ingredient Substances 0.000 title abstract 4
- 235000019253 formic acid Nutrition 0.000 title abstract 4
- 208000001145 Metabolic Syndrome Diseases 0.000 title abstract 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 238000009825 accumulation Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000037396 body weight Effects 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000013376 functional food Nutrition 0.000 abstract 1
- 235000013402 health food Nutrition 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229940127554 medical product Drugs 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
본 발명은 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물; 상기 유효성분을 포함하는 식품 조성물 및 건강기능식품에 관한 것이다. 본 발명에 따른 포름산 생성능이 우수한 균주는 체중 감소 및 장기의 지방 축적 억제 효과를 가질 뿐 아니라, 혈중 중성지방과 콜레스테롤의 수치를 효과적으로 낮추는 활성을 갖는바, 이를 유효성분으로 포함하는 조성물은 비만 또는 비만으로부터 야기되는 대사증후군를 예방/개선하거나 치료할 수 있는 조성물로서 유용하게 사용될 수 있다. 따라서 본 발명에 따른 포름산 생성능이 우수한 균주는 의약품 또는 건강식품 소재로서 유용하게 사용될 수 있다.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019547566A JP7012736B2 (ja) | 2016-11-21 | 2017-11-21 | ギ酸生成能に優れた菌株を有効成分として含む肥満または肥満によって惹起された代謝症候群の予防または治療用組成物 |
US16/462,901 US11564955B2 (en) | 2016-11-21 | 2017-11-21 | Composition including, as active ingredient, strain having ability to produce formic acid for preventing or treating obesity or metabolic syndromes caused by obesity |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160154978A KR101912774B1 (ko) | 2016-11-21 | 2016-11-21 | 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 |
KR10-2016-0154978 | 2016-11-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2018093238A2 WO2018093238A2 (ko) | 2018-05-24 |
WO2018093238A3 true WO2018093238A3 (ko) | 2018-08-09 |
Family
ID=62145598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2017/013297 WO2018093238A2 (ko) | 2016-11-21 | 2017-11-21 | 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 |
Country Status (4)
Country | Link |
---|---|
US (1) | US11564955B2 (ko) |
JP (1) | JP7012736B2 (ko) |
KR (1) | KR101912774B1 (ko) |
WO (1) | WO2018093238A2 (ko) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220313750A1 (en) * | 2019-10-24 | 2022-10-06 | Doctor Tj Co., Ltd | Composition containing enterococcus faecalis as active ingredient for preventing or treating obesity or metabolic syndromes induced thereby |
JP7153274B2 (ja) * | 2019-12-25 | 2022-10-14 | 京都府公立大学法人 | 慢性腎臓病進行抑制剤 |
CN114901296A (zh) * | 2019-12-27 | 2022-08-12 | 国立大学法人神户大学 | 毛细血管疾病抑制剂、毛细血管疾病改善剂、以及毛细血管新生促进剂 |
KR102512802B1 (ko) * | 2020-04-21 | 2023-03-23 | 한국식품연구원 | 포름산 생성능이 우수한 엔테로코커스 패칼리스 tk1 균주, 이를 포함하는 항비만용 식품 조성물 및 이의 제조방법 |
CN115245523A (zh) * | 2021-01-28 | 2022-10-28 | 上海市第六人民医院 | 青春双歧杆菌在制备脂肪吸收抑制剂中的应用 |
CN114042091A (zh) * | 2021-10-24 | 2022-02-15 | 郑州大学 | 酪黄肠球菌在制备治疗代谢综合征产品中的应用方法 |
CN115466689B (zh) * | 2022-02-09 | 2023-06-16 | 中国科学技术大学 | 用于预防和/或治疗代谢类疾病的益生菌组合物及其应用 |
CN117625478A (zh) * | 2023-11-29 | 2024-03-01 | 广西爱生生命科技有限公司 | 一种具有治疗非酒精性脂肪肝和/或减脂功能的戊糖片球菌菌株a21243及其应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002080357A (ja) * | 2000-09-05 | 2002-03-19 | Kao Corp | 高血圧症予防・改善・治療剤 |
JP2002530326A (ja) * | 1998-11-25 | 2002-09-17 | ヨマー、ファルマカ、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング | 感染症の治療のためのホスホノ蟻酸誘導体の使用 |
KR20130001744A (ko) * | 2011-06-24 | 2013-01-07 | (주)이뮤노텍 | 유기산, l―카르니틴, l―아르기닌 및 니코틴아미드를 유효성분으로 포함하는 비만의 예방 및 개선용 조성물 |
EP2716167A1 (en) * | 2012-10-02 | 2014-04-09 | Lunamed AG | Non-pharmaceutical composition comprising short chain fatty acids |
KR20160066253A (ko) * | 2014-12-02 | 2016-06-10 | (주)아모레퍼시픽 | 이카리시드 b2를 함유하는 대사 증후군 예방 또는 개선용 조성물 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63280027A (ja) | 1987-05-11 | 1988-11-17 | Nichinichi Shokuhin Kk | 抗高脂血症剤 |
US6787348B1 (en) * | 1998-08-26 | 2004-09-07 | Chr. Hansen | Liquid starter cultures having improved storage stability and use thereof |
JPWO2005077390A1 (ja) | 2004-02-16 | 2007-08-02 | 康雄 河合 | 血糖値低下剤、糖尿病治療・予防剤及びその製造方法 |
JP5569710B2 (ja) | 2009-02-27 | 2014-08-13 | 国立大学法人広島大学 | 肥満予防又は改善剤 |
KR101508586B1 (ko) * | 2013-10-21 | 2015-04-08 | 한국식품연구원 | 비만억제능이 우수한 신규한 엔테로코커스 휘칼리스 md366 균주 |
KR101611829B1 (ko) * | 2015-06-08 | 2016-04-14 | 주식회사 쎌바이오텍 | 비만 및 비만으로 야기된 대사성 질환의 예방 또는 치료를 위한 페디오코커스 펜토사세우스 cbt sl4 균주 및 이를 포함하는 조성물 |
CN109219656A (zh) | 2016-09-06 | 2019-01-15 | 深圳华大生命科学研究院 | 长栖粪杆菌(Faecalibacterium longum)及其应用 |
CN109072173A (zh) | 2016-09-06 | 2018-12-21 | 深圳华大生命科学研究院 | 克里斯坦森氏菌(Christensenella intestinihominis)及其应用 |
-
2016
- 2016-11-21 KR KR1020160154978A patent/KR101912774B1/ko active IP Right Grant
-
2017
- 2017-11-21 WO PCT/KR2017/013297 patent/WO2018093238A2/ko active Application Filing
- 2017-11-21 US US16/462,901 patent/US11564955B2/en active Active
- 2017-11-21 JP JP2019547566A patent/JP7012736B2/ja active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002530326A (ja) * | 1998-11-25 | 2002-09-17 | ヨマー、ファルマカ、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング | 感染症の治療のためのホスホノ蟻酸誘導体の使用 |
JP2002080357A (ja) * | 2000-09-05 | 2002-03-19 | Kao Corp | 高血圧症予防・改善・治療剤 |
KR20130001744A (ko) * | 2011-06-24 | 2013-01-07 | (주)이뮤노텍 | 유기산, l―카르니틴, l―아르기닌 및 니코틴아미드를 유효성분으로 포함하는 비만의 예방 및 개선용 조성물 |
EP2716167A1 (en) * | 2012-10-02 | 2014-04-09 | Lunamed AG | Non-pharmaceutical composition comprising short chain fatty acids |
KR20160066253A (ko) * | 2014-12-02 | 2016-06-10 | (주)아모레퍼시픽 | 이카리시드 b2를 함유하는 대사 증후군 예방 또는 개선용 조성물 |
Also Published As
Publication number | Publication date |
---|---|
JP7012736B2 (ja) | 2022-02-14 |
US11564955B2 (en) | 2023-01-31 |
WO2018093238A2 (ko) | 2018-05-24 |
US20210315946A1 (en) | 2021-10-14 |
KR101912774B1 (ko) | 2018-10-29 |
KR20180056972A (ko) | 2018-05-30 |
JP2019535828A (ja) | 2019-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018093238A3 (ko) | 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 | |
UA122342C2 (uk) | Спосіб інгібування всмоктування та/або прискорення виведення ліпідів за допомогою d-псикози | |
PH12018501988A1 (en) | Agent for increasing intestinal butyric acid and proliferation agent for butyric acid-producing bacteria | |
MX354875B (es) | Composiciones y métodos para mejorar la función mitocondrial y tratar enfermedades neurodegenerativas y trastornos cognitivos. | |
MY197024A (en) | Amylin analogues | |
PH12016500762A1 (en) | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children | |
WO2016190683A8 (ko) | 길경 추출물을 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물 | |
WO2019066577A3 (ko) | 짧은 사슬 지방산 생성 장내 세균 군집의 변화를 이용한 알코올성 간 질환의 진단 및 치료용 조성물 | |
TN2012000428A1 (en) | Bisaryl-bonded aryltriazolones and use thereof | |
WO2016190682A3 (ko) | 모루신, 구와논 지 또는 상백피를 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물 | |
WO2017022962A8 (ko) | Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
WO2018169282A3 (ko) | Atpif1을 함유하는 당뇨 치료용 약학조성물 | |
EP4219714A3 (en) | Rna interference mediated inhibition of tmprss6 | |
EA033540B1 (ru) | Композиция, включающая окру, для применения в уменьшении абсорбции пищевого жира | |
IN2014DN08240A (ko) | ||
PH12019501439A1 (en) | Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus | |
WO2018093237A3 (ko) | 포름산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 | |
WO2016190566A3 (ko) | 아위버섯 물 추출물을 유효성분으로 함유하는 대사성질환의 예방 및 치료용 약학적 조성물 또는 건강기능성식품 | |
MX2015005733A (es) | Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad. | |
WO2016048005A3 (ko) | 신규한 펜타디에노일 피페리딘 유도체 및 그의 용도 | |
WO2011118957A3 (ko) | 파프리카 추출물을 함유하는 염증, 알레르기 또는 천식 질환 치료용 조성물 | |
SG10201900961PA (en) | Agent for promoting production of ceramide covalently bound to horny layer cell | |
WO2016008642A3 (en) | Compositions comprising cinnamaldehyde and zinc and methods of using such compositions | |
WO2012105816A3 (ko) | 새콩 분말 또는 이의 추출물을 포함하는 당뇨병 및 당뇨합병증 예방 및 치료를 위한 조성물 | |
MX2023005014A (es) | Metodos de tratamiento de enfermedades inflamatorias cronicas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17871255 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2019547566 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17871255 Country of ref document: EP Kind code of ref document: A2 |